Background-Specific bronchial reactivity to occupational agents may decline after exposure in the workplace ceases leading to falsely negative specific inhalation challenges. A study was carried out to assess prospectively whether increases in nonspecific bronchial hyperresponsiveness could be useful in detecting the bronchial response to occupational agents during specific inhalation challenges. Methods -Specific inhalation challenges were performed in 66 subjects with possible occupational asthma due to various agents. After a control day the subjects were challenged with the suspected agent for up to two hours on the first test day. Those subjects who did not show an asthmatic reaction were rechallenged on the next day for 2-3 hours. The provocative concentration of histamine causing a 20% fall (PC20) in the forced expiratory volume
Background-Specific bronchial reactivity to occupational agents may decline after exposure in the workplace ceases leading to falsely negative specific inhalation challenges. A study was carried out to assess prospectively whether increases in nonspecific bronchial hyperresponsiveness could be useful in detecting the bronchial response to occupational agents during specific inhalation challenges. Methods -Specific inhalation challenges were performed in 66 subjects with possible occupational asthma due to various agents. After a control day the subjects were challenged with the suspected agent for up to two hours on the first test day. Those subjects who did not show an asthmatic reaction were rechallenged on the next day for [2] [3] hours. The provocative concentration of histamine causing a 20% fall (PC20) in the forced expiratory volume in one second (FEVy) was assessed at the end of the control day as well as six hours after each challenge that did not cause a >20% fall in FEV1. The subjects who had a significant ( > 3.1-fold) reduction in PC20 value at the end of the second challenge day were requested to perform additional specific inhalation challenges. Results -The first test day elicited an asthmatic reaction in 25 subjects. Of the other 41 subjects five (12%, 95% confidence interval (CI) 4% to 26%) exhibited a . 3o 1-fold fall in the PC20 value after the inhalation challenge and developed an asthmatic reaction during the second (n =3) or third (n =2) challenge exposure. The offending agents included persulphate (n = 1), wood dust (n = 2), isocyanate (n = 1), or amoxycillin (n = 1). These five subjects had left their workplace for a longer period (mean (SD) 21 (14) months) than those who reacted after the first specific inhalation challenge (8 (11) 
months).
Conclusions -The increase in non-specific bronchial hyperresponsiveness after a specific inhalation challenge can be an early and sensitive marker ofbronchial response to occupational agents, especially in subjects removed from workplace exposure for a long time. Non-specific bronchial hyperresponsiveness should be systematically assessed after specific in- Occupational asthma is increasingly recognised as the most common cause of work related respiratory disease in industrialised countries.' Affected workers should be completely and definitively removed from exposure to the causative agent in order to prevent further deterioration of asthma and to minimise long term sequelae.2 The medical and socioeconomic consequences of occupational asthma34 make reliable diagnosis important. Monitoring of peak expiratory flow rates (PEFR) at work and away from work is useful in assessing the work-relatedness of asthma, [5] [6] [7] although the procedure cannot be carried out when subjects have left or lost their job.
Although specific inhalation challenges are still regarded as the gold standard method for confirming occupational asthma,5-7 a negative result does not absolutely rule out the diagnosis of occupational asthma. Specific bronchial reactivity to occupational agents may decline after removal from exposure8-" and may reappear when the subjects are re-exposed to the offending agent.89 Similar changes have been documented with non-specific bronchial hyperresponsiveness."213 An isolated observation of a subject with occupational asthma due to Western red cedar suggested that an increase in bronchial hyperresponsiveness may precede the development of an asthmatic reaction. '4 Challenge exposure to red cedar carried out three months after the subject had left his work caused an increase in bronchial hyperresponsiveness in the absence of significant changes in airway calibre. An asthmatic reaction was elicited only by challenging the subject for longer periods on the following days.
The aim of this study was to evaluate prospectively whether increases in non-specific bronchial hyperresponsiveness could be useful in detecting the bronchial response to occupational agents during specific inhalation challenges. Non-specific bronchial hyperresponsiveness to histamine was assessed on a control day and after each challenge that did not elicit significant airways obstruction. In the absence of an asthmatic reaction challenge exposure to the suspected occupational agent was repeated at least once on the next day before excluding occupational asthma.
Methods

SUBJECTS
Sixty six consecutive subjects investigated for possible occupational asthma over a two year period were included in the study. They were referred for specific inhalation challenge tests either by their attending physician (n = 14) or by the Belgian Workers' Compensation Board (n = 52). These tests were carried out when other diagnostic tests did not provide conclusive results. The subjects completed a detailed medical and occupational questionnaire and all reported work related respiratory symptoms consistent with occupational asthma caused by various agents (table 2) . They were skin prick tested with common inhaled allergens and with occupational agents such as flour and latex when available. Atopy was defined by the presence of a positive skin reaction to at least one of the common allergens. The procedures used in the study were approved by the local ethics committee.
STUDY DESIGN
The subjects underwent specific inhalation challenges and assessment of non-specific bronchial hyperresponsiveness according to a standardised protocol. On the control day, subjects were exposed to a control product -for example, lactose powder, pine dust, diluent usually mixed with the tested compoundfor 30-60 minutes and spirometric parameters were monitored for six hours to ensure that fluctuations of forced expiratory volume in one second (FEV,) were < 10%. The baseline level of non-specific bronchial hyperresponsiveness to histamine was determined at the end of the control day. On the next day (first test day) the subjects were challenged with the suspected occupational agent. The duration of exposure was progressively increased (one, four, 15, 40, 60 minutes) until a . 20% fall in FEVI occurred or a cumulative exposure of two hours was completed. Non-specific bronchial hyperresponsiveness was reassessed six hours after the end of the exposure in the absence of significant changes in FEV1. Those Specific inhalation challenges were performed according to recent guidelines.15 6 Anti-asthmatic medications were withheld for the intervals recommended. Treatment with inhaled and oral corticosteroids was continued but the total daily dose was given in the evening of each day (at least 10 hours before the next test) to maintain asthma stability throughout the challenge tests.'6 A short acting inhaled bronchodilator (salbutamol, 200,g) was given on demand after 56% of assessments of bronchial hyperresponsiveness following the challenge tests had been made.
Spirometric values were obtained before exposure and were reassessed every 15 minutes for the first hour, every 30 minutes for the second hour, and then hourly for at least six hours after the end of exposure. The PEFR was monitored hourly during the day and evening as well as at night whenever required. Specific inhalation challenges were considered positive when a sustained fall of .20% in FEV, was recorded on two consecutive assessments. '5 16 The pattern of bronchial responses was characterised as immediate, late, dual (immediate followed by a late component), or atypical according to previously described criteria. 7 18 Subjects with negative challenge tests were requested to record their PEFR every two hours for at least two weeks at work.
Specific inhalation challenges were carried out in 5 m3 challenge rooms equipped with an exhaust ventilation system and a small fan to ensure air mixing. On active test day(s) the subjects were exposed to the occupational agent suspected of being the cause of work related asthma, based on their clinical history and inspection of the workplace by Workers' Compensation Board hygienists. Challenge exposures to occupational agents were produced in different ways depending on the nature and the physical state of the agent encountered at the workplace (dust, aerosol, vapour, or fume). Agents in powder form -for example, flour, wood dusts, antibiotics, persulphate saltswere poured from one tray to another as proposed by Pepys et al. 7 Isocyanates were generated by evaporation at ambient temperature (toluene diisocyanate), nebulisation (prepolymers of hexamethylene diisocyanate), or heating (diphenylmethane diisocyanate). 16 9 Isocyanate concentrations were continuously monitored using an MDA 7100 tape monitor (MDA Scientific Inc, Glenview, Illinois, USA) and kept below the threshold limit value of 20 ppb. Subjects with suspected latex induced asthma were challenged by exposure to airborne natural rubber latex from handling latex gloves, as previously described.2U Specific inhalation challenges with other agents were performed in order to reproduce the workplace exposure as closely as possible.
ASSESSMENT OF NON-SPECIFIC BRONCHIAL HYPERRESPONSIVENESS
Non-specific bronchial hyperresponsiveness was assessed using the standardised procedure described by Cockcroft et al." Doubling con- (12) 1 (20) 3 (8) FEV, =forced expiratory volume in one second; FVC forced vital capacity; PC20 =concentration provoking a 20% fall in FEV,.
* p<0 05 versus subjects who showed a positive inhalation challenge on the first test day; t p<0 05 versus subjects who showed a positive inhalation challenge on the first test day and those with a negative test result.
centrations of histamine from 0 03 to 16 mg/ ml were delivered with a Wright's nebuliser (output=0-14ml/min) at tidal breathing for two minutes. The provocative concentration of histamine causing a 20% fall in FEV1 (PC2O) was interpolated from the individual dose response curve. Histamine PC20 was assessed at the end of the control day (baseline value) and reassessed 6-7 hours after each challenge exposure that did not induce significant bronchial reaction, when FEV, was within + 10%
of the corresponding control day value. The changes in histamine PC20 values were expressed as the ratio of the PC20 on the control day to the PC20 following challenge. Non-specific bronchial hyperresponsiveness was con- sidered to be significantly increased following inhalation challenge when this ratio was > 3-1 -that is, when a . 3 l-fold reduction in PC20 value was recorded after inhalation challenge -as this figure represents the mean +2 SD of the ratio between two PC20 values determined in 18 clinically stable asthmatic subjects assessed at the same time of day on two occasions separated by a 2-15 day interval.
ANALYSIS OF RESULTS
Histamine PC20 values were expressed as the geometric mean (SD) and compared using paired or unpaired Student's t tests after logarithmic transformation. Minutes Hours Figure 2 Results of specific inhalation challenges in subjects 3, 4, and 5 showing the changes in forced expiratory volume in one second (FEVJ and concentration of histamine provoking a 20% fall in FEV, (mglml) (PC20) after exposure to a control substance (0) and suspected allergens (0 hexamethylene diisocyanate (HDI) for subject 3, black meranti wood dust for subject 4, and amoxycillin for subject 5). S = inhaled f2 adrenergic agent (salbutamol, 200 rg).
In the remaining subjects with negative inhalation challenges the mean histamine PC20 values remained unchanged after the first (07 mg/ml) and second (09 mg/ml) test days compared with the control day (0-7 mg/ml). Unfortunately, recording of PEFR during workplace exposure could not be systematically obtained for the subjects with negative challenge tests. Most of them had resigned their jobs and were not allowed to be re-exposed at work or they were not interested in performing the procedure. The absence of occupational asthma could be further confirmed in five subjects by monitoring of PEFR. , ance of exposure.8'-" The outcome of specific bronchial reactivity to occupational agents after cessation of exposure has not been extensively investigated for obvious ethical reasons. It is therefore not known how long a subject should be exposed to an occupational agent before a specific inhalation challenge test can be considered negative. This study shows that prolonged challenge exposure to the offending agent may be required to provoke the reappearance of a specific bronchial response in subjects who have not been exposed for a prolonged period. Our study may, however, overestimate the proportion of subjects in whom repeated challenges are required to elicit an asthmatic reaction. The interval of time between the last exposure in the workplace and inhalation challenge was rather prolonged, with 55% of subjects being challenged more than three months after they had left work. In previous studies from which this information is available, most subjects were assessed within three months. 23 25 It is interesting that the five subjects who had a positive inhalation challenge test result after repeated challenges had been away from the workplace for a significantly longer time than the subjects who had positive test results after the first test day, although a threshold interval could not be reliably delineated.
Our data indicate that an increase in nonspecific bronchial hyperresponsiveness represents an early and reliable marker of subsequent bronchial response to occupational agents. The possibility that some ofthe subjects who showed no changes in FEV, nor in PC20 during the two test days would have developed an asthmatic reaction after further challenge exposures seems unlikely. The proportion of subjects with positive specific inhalation challenge tests (30 of 66, 45%) is similar to the figures (41-57%) reported in previous studies,23-28 including one study where monitoring of PEFR was combined with inhalation challenge tests.25 Furthermore, the cumulative duration of exposure to occupational agents in our protocol is longer than that used in other centres. 24 26 The absence of occupational asthma could be further excluded by monitoring of PEFR at work in the five subjects for whom this procedure could be carried out.
One possible criticism of our protocol is that isolated late reactions could have occurred had histamine challenges not been performed six hours after exposure. However, our subjects were challenged for at least two hours on two consecutive days before excluding occupational asthma. With such prolonged exposures late reactions are likely to develop within six hours after the end of exposure."8 Studies have shown that high doses of occupational agents and common allergens are associated with the development of an immediate response or with an earlier occurrence of the late response." '3 Furthermore, none of the subjects showed significant changes in PEFR in the evening and at night following negative specific inhalation challenge tests.
The rationale for assessing histamine PC20 six hours after the end of challenge exposure to occupational agents was based on current knowledge of the changes in non-specific bronchial hyperresponsiveness after allergen challenges, as well as on pragmatic considerations. Enhancement of non-specific bronchial hyperresponsiveness has been described in relation to late asthmatic reactions induced by occupational agents3' and common aeroallergens. 32 In these studies non-specific bronchial hyperresponsiveness increased 7-8 hours after allergen exposure and progressively returned to baseline level within a period of one day to four weeks. 31 An increase in non-specific bronchial hyperresponsiveness may precede the development of the late component of dual reactions occurring 1-3 hours after resolution of the immediate response.2933 Changes in nonspecific bronchial hyperresponsiveness have also been observed in a substantial proportion of subjects within 12 hours after isolated immediate reactions to various occupational agents.34 By contrast, the time course of changes in non-specific bronchial hyperresponsiveness after challenges that do not elicit an asthmatic reaction is unknown. The optimal timing for assessing post-challenge non-specific bronchial hyperresponsiveness therefore warrants further investigation. From a practical point of view, measurement of histamine PC20 at six hours after exposure makes it possible to avoid too long a stay in the laboratory for the subjects while permitting us to rechallenge them the next morning when indicated.
We conclude that changes in non-specific bronchial hyperresponsiveness represent early and sensitive markers of a bronchial response to occupational agents. Non-specific bronchial hyperresponsiveness should be systematically assessed after specific inhalation challenges. When monitoring of spirometric parameters is negative, a significant increase in postchallenge non-specific bronchial hyperresponsiveness means that further challenge exposure in the laboratory and/or in the workplace is needed before excluding the diagnosis of occupational asthma. Alternatively, reproducible increases in non-specific bronchial hyperresponsiveness could be considered as reflecting a significant bronchial response when changes in spirometric values do not fulfil the recommended criteria. This procedure should enhance the degree of confidence with which occupational asthma can be ruled out after specific inhalation challenge testing.
